Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

NCT00129181 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Parkinsonian Syndrome

Interventions

DRUG: cabergoline
DRUG: carbidopa/levodopa
PROCEDURE: DATscan and SPECT imaging

Sponsor

Institute for Neurodegenerative Disorders

Collaborators

[object Object]
[object Object]